What is the current price and short-term outlook for ALCAR.PA stock?

ALCAR.PA stock closed at **€0.099** on 29 Jan 2026. Short-term outlook is an oversold bounce target near **€0.18** if buying returns; maintain tight stops due to high volatility.

How does Carmat’s financial health affect the ALCAR.PA stock outlook?

Carmat shows negative EPS **-1.15**, limited cash per share **€0.206**, and high enterprise value to sales, increasing funding and execution risk and limiting long-term upside until metrics improve.

What trading strategy suits the oversold bounce setup in ALCAR.PA?

Use small position sizes, enter on volume-supported bounces above **€0.11**, set a stop below **€0.085**, and target **€0.18** for short-term trades while monitoring news and liquidity.

Where can I find official company updates for Carmat?

Company updates are available on Carmat’s official website and regulatory filings. For trading context check the market comparison on Investing.com and Carmat’s investor pages.

EU Stocks

ALCAR.PA Carmat SA EURONEXT market closed 29 Jan 2026: Oversold bounce at €0.099

ByHuzaifa Zahoor January 30, 2026January 30, 2026

ALCAR.PA stock closed at €0.099 on EURONEXT on 29 Jan 2026, marking a lower-range finish after heavy selling. The share traded between €0.097 and €0.110 on volume of 807,348, roughly in line with average volume of 797,166. Fundamentals remain weak with EPS -1.15 and a negative PE, but the share is technically oversold versus its 50-day average €0.148 and 200-day average €0.595. We see a defined oversold bounce setup for Carmat SA (ALCAR.PA) that may offer short-term trading opportunities, while broader healthcare sector trends remain mixed in Europe.